ARTICLE SUMMARY:
electroCore’s noninvasive vagus nerve stimulation device is the only device cleared for the prevention and treatment of cluster headache, and it’s also cleared for the prevention and treatment of migraine, a large market that has seen the entrant of four new players recently. The company is poised to capture a multibillion-dollar market, if only it can figure out the right strategy for US commercial payors. Part 1 of a two-part article on devices for migraine.
electroCore Inc., a leader in device therapies for the treatment of painful headaches such as migraine and cluster headache, was founded in 2005 to pursue a completely different indication, which is ironic since its founder Peter Staats, MD, is a luminary in the field of interventional pain.
